COVID19 No plan to make RTPCR testing mandatory airports Health Ministry sources latest updates

0
28
COVID19 No plan to make RTPCR testing mandatory airports Health Ministry sources latest updates


Image Source : PTI (FILE) A healthcare employee collects pattern of a lady for Covid-19 testing

COVID-19 India replace: There isn’t any plan to date to make RT-PCR testing for COVID-19 mandatory at airports for travellers, Union well being ministry sources mentioned right this moment (December 21), amid an uptick in coronavirus infections in India. Even although the variety of circumstances is rising and the JN.1 sub-variant has been detected within the nation, there isn’t any explanation for instant concern as 92 per cent of these contaminated are choosing home-based therapy, indicating delicate sickness, they mentioned.

There can also be no enhance in hospitalisation charges and COVID-19 is an incidental discovering in individuals hospitalised due to different medical situations. In the final two weeks, 22 individuals have died due to COVID-19 within the nation.

Corona infections:

India on Thursday recorded 594 recent COVID-19 infections whereas the variety of energetic circumstances elevated to 2,669 from 2,311 the day before today, in accordance to Union Health Ministry knowledge. The loss of life toll has climbed to 5,33,327 with six extra people- three from Kerala, two from Karnataka and one from Punjab- succumbing to the viral illness, the info up to date at 8:00 am acknowledged.

As many as 21 circumstances of the JN.1 variant had been detected throughout the nation until Wednesday. NITI Aayog member (Health) Dr VK Paul on Wednesday mentioned that the scientific neighborhood in India is intently investigating the brand new variant as he emphasised the necessity for states to ramp up testing and strengthen surveillance methods.

“There is no plan so far to make RT-PCR testing for COVID-19 mandatory at airports,” a supply mentioned.

Ex-ICMR DG on JN.1 COVID-19 variant: 

On JN.1 COVID variant, Dr Soumya Swaminathan, Former Director General, Indian Council of Medical Research (ICMR) mentioned, “We need to be cautious, but we don’t need to worry because we don’t have any data to suggest that this variant JN.1 is more severe or it’s going to cause more pneumonia, more death, so I think what we need to do is try to take the normal preventive measures that we are all now familiar with. We are all now very familiar with Omicron. So it’s the same family. So not much has changed, but 1 or 2 new mutations have come up. And that’s why I think WHO has said let’s keep a watch on it. It’s a variant of interest. It’s not a variant of concern.”

RT-PCR testing:

In July, India had issued revised pointers, dropping the requirement for RT-PCR primarily based testing of a random 2 per cent of travellers getting into India. In view of the latest surge in COVID-19 circumstances and the detection of the primary case of the JN.1 variant within the nation, the Centre has urged states and union territories to keep fixed vigil.

In a letter to states and union territories, Union Health Secretary Sudhansh Pant on Monday underlined the vital COVID-19 management and administration methods contemplating the upcoming festive season and suggested them to put in place requisite public well being measures to minimise the chance of enhance in transmission of the illness.

States have been urged to guarantee efficient compliance of the detailed operational pointers for revised surveillance technique for COVID-19 shared by the Union Ministry of Health and Family Welfare. They have requested to monitor and report district-wise circumstances of Influenza-like Illness (ILI) and Severe Acute Respiratory Illness (SARI) in all well being amenities commonly for early detection of rising development of circumstances.

It will not be presently recognized whether or not the JN.1 an infection produces signs completely different from different variants, the ministry had mentioned. In basic, signs of COVID-19 have a tendency to be comparable throughout variants.

There can also be no indication of elevated severity from JN.1. At this time, there isn’t any proof that JN.1 presents an elevated threat to public well being in contrast to different presently circulating variants, in accordance to the ministry.

The current therapy line for COVID-19 is anticipated to be efficient in opposition to JN.1 an infection and up to date vaccines are anticipated to enhance safety in opposition to the variant, the ministry had mentioned.

(With companies inputs) 

ALSO READ: Covid sub-variant circumstances on the rise: Is JN.1 extra infectious and inflicting pneumonia? Explained

ALSO READ: Is Covid scare again? 300 recent circumstances reported, three deaths in Kerala

Latest India News





Source hyperlink